Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ

Gut

Volumn 50, Issue 2, 2002, Pages 191-195

  Tilg, H ^a   Van Montfrans, C ^b   Van den Ende, A ^b   Kaser, A ^a   Van Deventer, S J H ^b   Schreiber, S ^c   Gregor, M ^d   Ludwiczek, O ^a   Rutgeerts, P ^e   Gasche, C ^f   Koningsberger, J C ^g   Abreu, L ^h   Kuhn, I ⁱ   Cohard, M ^j   LeBeaut, A ^j   Grint, P ^j   Weiss, G ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF VIENNA   (Austria)

^g UTRECHT UNIVERSITY   (Netherlands)

^h Club of Madrid   (Spain)

ⁱ Merck Sharp and Dohme GesmbH   (Austria)

^j MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NEOPTERIN; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; RECOMBINANT INTERLEUKIN 10;

ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION;

ADMINISTRATION, CUTANEOUS; CHRONIC DISEASE; COLITIS; CROHN DISEASE; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FOLLOW-UP STUDIES; HUMANS; ILEITIS; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MONOCYTES; NEOPTERIN; NITRATES; NITRITES; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES;

EID: 0036153395     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.2.191     Document Type: Article

References (27)

1. Interleukin-10 and the interleukin-10 receptor
2. Interleukin-10-deficient mice develop chronic enterocolitis
3. Recombinant human Interleukin-10 in the treatment of patients with mild to moderately active Crohn's disease
4. Safety and efficacy of recombinant human interleukin-10 in chronic active Crohn's disease
5. Proinflammatory effects of interleukin-10 during human endotoxemia
6. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma
7. The L-arginine-nitric oxide pathway
8. Regulation of biosynthesis of nitric oxide
9. [15N]nitrate in biological fluids
10. Inteleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
11. IL-10 inhibits cytokine production by activated macrophages
12. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma·production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
13. Macrophage deactivation by interleukin 10
14. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
15. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts
16. Interleukin-10 induction by IL-12: A possible modulatory mechanism?
17. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma
18. Neopterin excretion after liver transplantation and its value in differential diagnosis of complications
19. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages
20. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)
21. Neopterin and prognosis in patients with adenocarcinoma of the colon
22. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
23. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes
24. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation
25. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
26. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease